Nynomic AG Enters Next Phase of Growth

Nynomic AG has shown significant growth and is entering a new phase, according to recent research from NuWays AG. In Q2, Nynomic AG reported a sales increase of 18.1% year-on-year, totaling €25.4 million. For the first half of the year, sales reached €47.7 million, marking a 13.3% increase compared to the previous year. The growth is attributed mainly to the high demand in semiconductor solutions, MedTech, and gas analysis.

The company benefits from investments in AI-related production infrastructures, with technologies such as LayTec’s metrology systems playing a critical role. The order backlog at the end of H1 was €63.5 million, up 46% year-on-year, supporting a positive outlook. Earnings before interest and taxes (EBIT) in Q2 improved by €1.7 million, driven by cost savings and increased revenue.

Management remains conservative with its full-year guidance, predicting sales of €100-105 million and an EBIT margin of 6-8%. However, given the positive indicators, the upper targets seem achievable. Overall, Nynomic AG is well-positioned for ongoing growth, particularly in the semiconductor industry.